Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-13-002862
Filing Date
2013-07-22
Accepted
2013-07-22 12:34:27
Documents
3
Period of Report
2013-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_072213.htm 6-K 11019
2 EXHIBIT 1 exh_1.htm EX-1 51489
3 EXHIBIT 2 exh_2.htm EX-2 261823
  Complete submission text file 0001171843-13-002862.txt   325245
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 13978802
SIC: 2834 Pharmaceutical Preparations